-
HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS)
Источник: Buzz FX / 08 окт 2024 16:22:11 America/New_York
HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" rating reissued
Read more...